Edwards Lifesciences Corp. Stock Climbs 3.1%, Outperforms Market

Dow Jones
2025/08/21

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. advanced 3.1% to $81.39 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 44,938.31 and the S&P 500 Index falling 0.2% to 6,395.78.

This was the stock's sixth consecutive day of gains.

Edwards Lifesciences Corp. closed 1.9% below its 52-week high of $83.00, which the company reached on July 25th.

The stock demonstrated a mixed performance when compared to some of its competitors, as Abbott Laboratories rose 0.9% to $132.44, Medtronic PLC rose 3.7% to $93.22, and Stryker Corp. rose 0.49% to $391.87.

Trading volume totaled 5.0 million, compared to the 50-day average of 4.2 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

August 20, 2025 16:35 ET (20:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10